PHAT
Price
$18.49
Change
-$0.00 (-0.00%)
Updated
Sep 17 closing price
49 days until earnings call
TNFA
Price
$1.25
Change
-$0.00 (-0.00%)
Updated
Sep 17 closing price
Ad is loading...

PHAT vs TNFA

Header iconPHAT vs TNFA Comparison
Open Charts PHAT vs TNFABanner chart's image
Phathom Pharmaceuticals
Price$18.49
Change-$0.00 (-0.00%)
Volume$1.38M
CapitalizationN/A
TNF Pharmaceuticals
Price$1.25
Change-$0.00 (-0.00%)
Volume$16.02K
CapitalizationN/A
View a ticker or compare two or three
PHAT vs TNFA Comparison Chart
Loading...
PHAT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TNFA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
PHAT vs. TNFA commentary
Sep 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHAT is a Hold and TNFA is a StrongSell.

COMPARISON
Comparison
Sep 19, 2024
Stock price -- (PHAT: $18.49 vs. TNFA: $1.25)
Brand notoriety: PHAT and TNFA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PHAT: 144% vs. TNFA: 32%
Market capitalization -- PHAT: $1.31B vs. TNFA: $2.96M
PHAT [@Biotechnology] is valued at $1.31B. TNFA’s [@Biotechnology] market capitalization is $2.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $599.73B to $0. The average market capitalization across the [@Biotechnology] industry is $3.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PHAT’s FA Score shows that 0 FA rating(s) are green whileTNFA’s FA Score has 1 green FA rating(s).

  • PHAT’s FA Score: 0 green, 5 red.
  • TNFA’s FA Score: 1 green, 4 red.
According to our system of comparison, TNFA is a better buy in the long-term than PHAT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PHAT’s TA Score shows that 3 TA indicator(s) are bullish while TNFA’s TA Score has 5 bullish TA indicator(s).

  • PHAT’s TA Score: 3 bullish, 4 bearish.
  • TNFA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, TNFA is a better buy in the short-term than PHAT.

Price Growth

PHAT (@Biotechnology) experienced а +3.24% price change this week, while TNFA (@Biotechnology) price change was -19.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.17%. For the same industry, the average monthly price growth was +1.67%, and the average quarterly price growth was -2.02%.

Reported Earning Dates

PHAT is expected to report earnings on Nov 06, 2024.

Industries' Descriptions

@Biotechnology (+1.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHAT($1.32B) has a higher market cap than TNFA($2.96M). TNFA YTD gains are higher at: 383.185 vs. PHAT (102.519). TNFA has higher annual earnings (EBITDA): -13.4M vs. PHAT (-238.33M). PHAT has more cash in the bank: 276M vs. TNFA (13.1M). TNFA has less debt than PHAT: TNFA (25.8K) vs PHAT (175M). PHAT has higher revenues than TNFA: PHAT (9.92M) vs TNFA (0).
PHATTNFAPHAT / TNFA
Capitalization1.32B2.96M44,381%
EBITDA-238.33M-13.4M1,779%
Gain YTD102.519383.18527%
P/E RatioN/AN/A-
Revenue9.92M0-
Total Cash276M13.1M2,107%
Total Debt175M25.8K678,295%
FUNDAMENTALS RATINGS
TNFA: Fundamental Ratings
TNFA
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PHATTNFA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 7 days ago
90%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 7 days ago
77%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
86%
Bullish Trend about 1 month ago
82%
Declines
ODDS (%)
Bearish Trend 10 days ago
83%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
PHAT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TNFA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NEOYX32.930.18
+0.55%
Natixis Oakmark Y
TRMCX35.870.15
+0.42%
T. Rowe Price Mid-Cap Value
PSYGX78.610.30
+0.38%
Putnam Small Cap Growth Y
EDIRX11.14N/A
N/A
Eaton Vance Global Income Builder R
LGCRX16.36-0.04
-0.24%
Lord Abbett Global Equity R3

TNFA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNFA has been loosely correlated with TVGN. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if TNFA jumps, then TVGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNFA
1D Price
Change %
TNFA100%
+3.31%
TVGN - TNFA
52%
Loosely correlated
-1.57%
COGT - TNFA
39%
Loosely correlated
-2.77%
PHAT - TNFA
39%
Loosely correlated
-2.12%
HEPA - TNFA
32%
Poorly correlated
+2.74%
LRMR - TNFA
32%
Poorly correlated
+1.79%
More